Healthcare IT News: Genome therapy is a part of precision medicine that is slowly going mainstream as policy clarifies reimbursement. The National Institutes of Health, for instance, is working on removing barriers that slow the adoption of genome editing for treating patients.
NIH announced this week the launch of Somatic Cell Genome Editing, a program aimed at picking up the pace in which the technology moves to the clinic for treatment.
Starting this year, NIH will award an estimated $190 million to researchers over six years, pending the availability of funds. The program is funded by NIH's Common Fund.
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now